A modest increase in risk translates into a large impact on the health care system.
At the threshold between hospital and home, a quiet danger has been hiding in plain sight: the routine prescription of sedatives to older adults at the moment of discharge. Canadian researchers examining nearly two million seniors found that those sent home with newly initiated sedatives faced a 20 percent higher risk of falls, emergency visits, readmission, and death within thirty days — not because sedatives are inherently catastrophic, but because they are being introduced at the precise moment when aging bodies are most fragile. The findings invite medicine to examine not just what it prescribes, but the unexamined habits that shape the prescribing.
- A study of 1.86 million seniors reveals that newly prescribed sedatives at hospital discharge raise the risk of falls, emergency visits, readmissions, and death by 20 percent within the following month.
- One in three patients who filled these prescriptions had never taken a sedative before — meaning they were not continuing familiar medications, but starting something new while their bodies were already weakened.
- The danger is not sedative use itself: patients who had been on these drugs before hospitalization showed no elevated risk, pointing specifically to new initiation during a vulnerable recovery window.
- Though the individual risk increase is modest, multiplied across millions of annual discharges it translates into an enormous cumulative burden of harm, cost, and preventable decline.
- Clinicians are now being urged to question whether each sedative prescription is truly necessary, to deprescribe or reduce doses before discharge, and to ensure follow-up within one to two weeks rather than months later.
- The research exposes a system that has normalized a risky practice — and asks whether the next discharge prescription is a clinical necessity or simply a habit no one has stopped to question.
A patient leaves the hospital with a discharge summary and a stack of prescriptions. For many older adults, one of those prescriptions is new — a sedative meant to ease anxiety or aid sleep. Research now shows that this handoff from hospital to home carries a hidden danger that has long gone unexamined.
Canadian researchers studying more than 1.86 million adults aged 66 and older found that seniors discharged with a newly prescribed sedative faced a 20 percent higher risk of falls within the following month, along with increased rates of emergency visits, hospital readmission, and death within 30 days. The findings, published in the Canadian Medical Association Journal, challenge a routine practice that has rarely been scrutinized.
Among the study population, roughly 13 percent filled a sedative prescription within a week of coming home — and about one-third of those patients had no prior sedative use in the six months before hospitalization. They were not continuing a familiar medication. They were starting something new at a moment when their bodies were already compromised by acute illness. Led by Dr. Lisa Burry of Mount Sinai Hospital and the University of Toronto, the research found that elevated risks applied specifically to these newly initiated patients, not to those continuing pre-existing prescriptions.
The authors note that while the absolute risk increase for any single patient is modest, multiplied across millions of annual discharges it becomes an enormous collective burden — more falls, more fractures, more emergency beds occupied, more lives quietly derailed at the start of what should have been recovery.
The researchers urge clinicians to pause before writing these prescriptions, to deprescribe or reduce doses before discharge where possible, and to ensure medical follow-up within one to two weeks rather than months later. Community-based supports like mobility assessments could help those who genuinely need the medications.
What the study ultimately reveals is a system that has developed habits without questioning them — prescribing medications known to carry risks for older adults at the very moment those adults are most vulnerable. It does not explain why the habit persists, but it makes clear that the question deserves to be asked at every discharge: is this prescription truly necessary, or is it simply routine?
A patient leaves the hospital with a discharge summary, a stack of prescriptions, and instructions to rest at home. For many older adults, one of those prescriptions is new: a sedative, perhaps a benzodiazepine or an antipsychotic meant to calm anxiety or help with sleep. What the research now shows is that this moment—the handoff from hospital to home—carries hidden danger.
Canadian researchers studying more than 1.86 million adults aged 66 and older found that seniors discharged with a newly prescribed sedative faced a 20 percent higher risk of falls within the following month. But falls were only part of the story. These patients also experienced increased rates of emergency department visits, hospital readmission, and death in the 30 days after leaving the hospital. The findings, published in the Canadian Medical Association Journal, challenge a common practice that has long gone largely unexamined: the routine prescribing of these medications at the moment of discharge.
The scale of the problem is substantial. Among the 1.86 million patients in the study, discharged between April 2003 and August 2023, roughly 13 percent—nearly a quarter-million people—filled at least one sedative prescription within a week of coming home. What made this particularly striking was that about one-third of those patients had never taken a sedative in the six months before their hospitalization. They were not continuing a medication they had been on. They were starting something new at a moment when their bodies were already weakened by acute illness.
Dr. Lisa Burry, a clinician scientist at Mount Sinai Hospital and the University of Toronto, led the research team. In their analysis, they found that the increased hazards applied specifically to patients with no prior exposure to these drugs. Those who had been taking sedatives before admission and continued them after discharge did not show the same elevated risks. The distinction matters because it suggests the problem is not sedative use itself, but rather the initiation of sedative use during a vulnerable window—when an older person is physically compromised, their balance uncertain, their home environment unfamiliar in their weakened state.
The authors acknowledge that from a pure statistical standpoint, the absolute risk increase for any single patient is modest. But they note something crucial: when you multiply that modest increase across millions of hospital discharges each year, the cumulative burden on the health system becomes enormous. More falls mean more emergency visits. More readmissions mean more hospital beds occupied, more staff stretched thin, more costs absorbed. And some of those falls end in fractures, infections, or cascading complications that can mark the beginning of decline in an older person's life.
The research raises a straightforward question: Are these prescriptions necessary? The authors suggest that clinicians should pause before writing them. If a sedative is truly essential, they recommend ensuring that patients have medical follow-up within one to two weeks of discharge—not months later—to reassess whether the medication is still needed. They also propose that community-based support, such as falls assessments and mobility evaluations, could help mitigate the risks for those who do need these drugs. In some cases, deprescribing—actively removing the medication—or de-escalating to a lower dose before discharge might be the safer path.
What emerges from this research is a portrait of a system that has developed habits without always questioning them. Sedatives and antipsychotics are known to carry risks for older adults. Clinical guidelines have long discouraged their use in this population. Yet they continue to be prescribed at the moment when patients are most vulnerable. The study does not answer why this happens—whether it is habit, time pressure, inadequate communication between hospital and community providers, or simply the assumption that a medication prescribed must be a medication needed. But it does make clear that the current practice deserves scrutiny, and that the next hospital discharge you witness might be an opportunity to ask: Is this medication truly essential, or is it a prescription written out of routine?
Citas Notables
Discharging older adults with a new prescription for these medications was associated with an increased hazard of falls requiring medical attention, further need for acute hospital care, and death in the 30 days after hospital discharge, whereas individuals with prior exposure did not experience the same increased hazards.— Dr. Lisa Burry, Mount Sinai Hospital and University of Toronto
Clinicians must consider whether new sedative prescriptions are essential or can be deprescribed or de-escalated before or shortly after hospital discharge.— Study authors
La Conversación del Hearth Otra perspectiva de la historia
Why does it matter that these are new prescriptions rather than medications people were already taking?
Because it tells us the problem isn't sedatives themselves—it's starting them at the worst possible moment. An older person's body is already compromised after hospitalization. Their balance is off. Their strength is gone. Adding a drug that makes them drowsy or unsteady at that exact moment creates a collision of risks.
But surely doctors have a reason for prescribing them at discharge. What are they treating?
Anxiety, insomnia, agitation—things that are real and understandable after a hospital stay. The question the research raises is whether a sedative is the right tool, or whether there are safer alternatives, or whether waiting a few weeks to see if the symptoms resolve on their own might be wiser.
The study found modest absolute risk increases. Does that mean we're overstating the problem?
No. A modest increase per person becomes a massive problem when you're talking about millions of discharges. And for the individual who falls and breaks a hip, the risk wasn't modest at all—it was life-altering.
What would better practice look like?
A doctor would ask: Is this medication truly necessary right now, or can we wait? If yes, they'd ensure the patient sees someone within two weeks to reassess. They'd arrange for a home assessment—someone checking whether the house is safe, whether the person can walk without falling. They'd actively plan to stop the medication once it's no longer needed, rather than letting it become routine.
Who bears the cost of getting this wrong?
The patient bears it first—a fall, a fracture, maybe a cascade of complications. But the system bears it too. More emergency visits, more readmissions, more bed days. It's a cost that could be prevented by asking one question at discharge: Do we really need this?